Drawing for MEDWARE

USPTO serial 74076069

MEDWARE

Reviewed by CopyMark Law Group

Status 607
Filing date
Status date
Registration date
—
Examiner
CLARK, GLENN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDWARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009computer software for use in the field of medical office management and computer manuals sold therewithABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 25, 1992ABN7ABANDONMENT - DEFECTIVE USE STATEMENT—
Jun 15, 1992IUFFUSE AFFIDAVIT FAILED FORMALITIES—
Jan 13, 1992IUAFUSE AMENDMENT FILED—
Dec 24, 1991NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 2, 1991PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 1991NPUBNOTICE OF PUBLICATION—
Jan 14, 1991CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 31, 1990CNEAEXAMINER'S AMENDMENT MAILED—
Dec 4, 1990DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance